FORMULATION DETAILS
Tenofovir Disproxil Fumarate (A) + Lamivudine (B) Tablet 300 mg (A) + 300 mg (B): Information and Safety
Tenofovir Disproxil Fumarate (A) + Lamivudine (B) Tablet 300 mg (A) + 300 mg (B) is a catalogue formulation based on the NLEM listing. Strength and dosage form identify the product type, not a personal dose. Read the exact pack insert and use only with qualified advice.
Listed formulation
- Dosage form
- Tablet
- Strength / composition
- 300 mg (A) + 300 mg (B)
- Route
- Oral
- Product code
- Check the exact pack / prescription
- Paediatric listing
- Not specifically marked
Exact dose and maximum dose depend on the condition, patient, route, product label and clinical advice.